Cargando…

High pro-neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow-up

AIMS: Neurotensin (NT) is a gut hormone that promotes lipids absorption and controls appetite. Elevated circulating pro-NT, the stable precursor of NT, is associated with cardiovascular (CV) disease, metabolic syndrome (MS) and type 2 diabetes (T2D). Features of MS and insulin resistance are reporte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cimini, Flavia Agata, Barchetta, Ilaria, Bertoccini, Laura, Ceccarelli, Valentina, Baroni, Marco Giorgio, Melander, Olle, Cavallo, Maria Gisella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758622/ https://www.ncbi.nlm.nih.gov/pubmed/34455471 http://dx.doi.org/10.1007/s00592-021-01783-x

Ejemplares similares

New Insights in the Control of Fat Homeostasis: The Role of Neurotensin
por: Barchetta, Ilaria, et al.
Publicado: (2022)

Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity
por: Barchetta, Ilaria, et al.
Publicado: (2018)

Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children
por: Sentinelli, Federica, et al.
Publicado: (2023)

Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Granzyme B Expression in Visceral Adipose Tissue Associates With Local Inflammation and Glyco-Metabolic Alterations in Obesity
por: Cimini, Flavia Agata, et al.
Publicado: (2020)

The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V
por: Bertoccini, Laura, et al.
Publicado: (2017)

Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
por: Cimini, Flavia A, et al.
Publicado: (2017)

Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity
por: Ceccarelli, Valentina, et al.
Publicado: (2020)

Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future
por: Barchetta, Ilaria, et al.
Publicado: (2017)

Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Granzyme B in Inflammatory Diseases: Apoptosis, Inflammation, Extracellular Matrix Remodeling, Epithelial-to-Mesenchymal Transition and Fibrosis
por: Velotti, Francesca, et al.
Publicado: (2020)

Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis
por: Barchetta, Ilaria, et al.
Publicado: (2022)

WISP1 Is a Marker of Systemic and Adipose Tissue Inflammation in Dysmetabolic Subjects With or Without Type 2 Diabetes
por: Barchetta, Ilaria, et al.
Publicado: (2017)

COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity
por: Barchetta, Ilaria, et al.
Publicado: (2019)

Overview of studies of the vitamin D/vitamin D receptor system in the development of non-alcoholic fatty liver disease
por: Cimini, Flavia Agata, et al.
Publicado: (2019)

Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update
por: Cimini, Flavia Agata, et al.
Publicado: (2022)

Dynamic Changes of BVRA Protein Levels Occur in Response to Insulin: A Pilot Study in Humans
por: Cimini, Flavia Agata, et al.
Publicado: (2023)

Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus
por: Zampieri, Michele, et al.
Publicado: (2021)

No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
por: Barchetta, Ilaria, et al.
Publicado: (2016)

Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans
por: Bailetti, Diego, et al.
Publicado: (2022)

Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Reduced High-Density Lipoprotein Cholesterol Is an Independent Determinant of Altered Bone Quality in Women with Type 2 Diabetes
por: Dule, Sara, et al.
Publicado: (2023)

The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up study
por: Barchetta, I., et al.
Publicado: (2021)

Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes
por: Barchetta, Ilaria, et al.
Publicado: (2011)

Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study
por: Di Franco, Manuela, et al.
Publicado: (2015)

Hypovitaminosis D is Independently Associated with Metabolic Syndrome in Obese Patients
por: Barchetta, Ilaria, et al.
Publicado: (2013)

Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus
por: Cavallo, Maria Gisella, et al.
Publicado: (2012)

ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity
por: Bailetti, D., et al.
Publicado: (2018)

Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Imaging Neurotensin Receptor in Prostate Cancer With (64)Cu-Labeled Neurotensin Analogs
por: Deng, Huaifu, et al.
Publicado: (2017)

An obligatory role for neurotensin in high fat diet-induced obesity
por: Li, J., et al.
Publicado: (2016)

Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism
por: Villar, Beatriz, et al.
Publicado: (2021)

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
por: Tscharre, Maximilian, et al.
Publicado: (2022)

Bradykinin and Neurotensin Analogues as Potential Compounds in Colon Cancer Therapy
por: Szaryńska, Magdalena, et al.
Publicado: (2023)

The Anti-Apoptotic Role of Neurotensin
por: Devader, Christelle, et al.
Publicado: (2013)

Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease
por: Mohamed, Amal A, et al.
Publicado: (2022)

Endogenous CNS Expression of Neurotensin and Neurotensin Receptors Is Altered during the Postpartum Period in Outbred Mice
por: Driessen, Terri M., et al.
Publicado: (2014)

Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced Obesity
por: Wu, Zherui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gqef0fmjn0cgmehmrjk70l3ruk